Morgan Keegan a 'Home Run' for Raymond James: FBR (Update 2)
Stelmach's fourth-quarter estimate matches the consensus, but for 2012, the analyst estimates EPS of $2.65, which is ahead of the consensus estimate of $2.49.
While FBR was waiting for "further clarity on accretion" before revising its earnings estimates for Raymond James, Stelmach said the Morgan Keegan deal was "nicely accretive," at 3% for 2012, "excluding deal-related expenses." The analyst added that "using 2013 consensus, we get to RJF's modest 2%-3% accretion only by assuming zero cost savings. But, on an estimated $930 million expense base for Morgan Keegan, 5% to 10% in cost savings does not seem unreasonable."
Stelmach said that the "the operating leverage at Raymond James is underappreciated, and we expect RJF to outperform, absent any multiple expansion due to improved earnings, as the operating environment becomes more favorable, particularly in financial advisor production and investment banking activity.
Raymond James' shares traded for 14 times the consensus 2012 EPS estimate, as of Wednesday's close at $34.18.
Interested in more on Raymond James Financial? See TheStreet Ratings' report card for this stock. Shares of Stifel Financial (SF) of St. Louis were similarly valued at 14 times forward earnings, based on Wednesday's closing price of $32.93. Stifel is set to announce its fourth-quarter results on Feb. 13. Analysts expect the company to report fourth-quarter earnings of 43 cents a share. The consensus EPS estimate for 2012 is $2.39. Interested in more on Stifel Financial? See TheStreet Ratings' report card for this stock.-- Written by Philip van Doorn in Jupiter, Fla. To contact the writer, click here: Philip van Doorn. To follow the writer on Twitter, go to http://twitter.com/PhilipvanDoorn.
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
